INBX
Inhibrx Biosciences, Inc.
NASDAQHealthcareBiotechnologyUS
USD95.22
+1.59 (+1.70%)
Rating:C+
Company Profile
CEO
Mark Paul Lappe
IPO Date
2024-06-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$93.31
Prev. Close
$93.63
Day Low
$90.88
Day High
$96.16
52W Low
$12.80
52W High
$155.29
Market Cap
$1.40B
Volume
0.33M